Indivior Pharmaceuticals, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
INDV on Nasdaq
Location
North Chesterfield, VA
Fiscal year end
31 December
Latest financial report
26 Feb 2026

Quick Takeaways

  • INDV - Indivior Pharmaceuticals, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Equity -97%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+3493%</span>.
  • Most recent SEC facts end date: 31 Jan 2026.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2026-01-31) highlights Return On Equity -96.6%, Return On Assets 16.7%, and Operating Margin 21.1%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

52.8/100

Caution Confidence high

Return On Equity

-97%

Metric score 0.0/100

Return On Assets

17%

Metric score 100.0/100

Financial Health

Current Ratio
0.71x
Quick Ratio
0.49x
Debt to Equity
-7.43x

Strengths

Return On Assets, Operating Margin, and Current Ratio

Watchpoints

Return On Equity and Debt-to-equity

Key metrics snapshot

Return On Equity

-97%

YoY: +3493%

Industry median: -43% (n=675)

View history

Return On Assets

17%

YoY: +3564%

Industry median: -47% (n=673)

View history

Operating Margin

21%

YoY: +561%

Industry median: -121% (n=298)

View history

Current Ratio

0.71x

YoY: -20%

Industry median: 3.39x (n=667)

View history

Quick Ratio

0.49x

YoY: -21%

Industry median: 1.51x (n=289)

View history

Debt-to-equity

-7.43x

YoY:

Industry median: 0.26x (n=530)

View history

Revenues YoY

4.3%

YoY:

Industry median: 7.3% (n=302)

View history

NetIncomeLoss YoY

2900%

YoY:

Industry median: -0.93% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Equity -97% +3493%
Return On Assets 17% +3564%
Operating Margin 21% +561%

Financial Health

Metric Latest value YoY change
Current Ratio 0.71x -20%
Quick Ratio 0.49x -21%
Debt-to-equity -7.43x

Growth

Metric Latest value YoY change
Revenues YoY 4.3%
NetIncomeLoss YoY 2900%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 125,065,242
Common Stock, Value, Issued $62,000,000 0%
Weighted Average Number of Shares Outstanding, Basic 125,000,000 -5.3%
Weighted Average Number of Shares Outstanding, Diluted 128,000,000 -3.8%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $1,239,000,000 +4.3%
Operating Income (Loss) $262,000,000 +589%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $239,000,000 +1095%
Income Tax Expense (Benefit) $29,000,000 +123%
Earnings Per Share, Basic 1.68 +3260%
Earnings Per Share, Diluted 1.64 +3180%
Cash and Cash Equivalents, at Carrying Value $195,000,000 -39%
Accounts Receivable, after Allowance for Credit Loss, Current $253,000,000 -0.39%
Inventory, Net $153,000,000 -8.4%
Other Assets, Current $16,000,000 -24%
Assets, Current $652,000,000 -21%
Deferred Income Tax Assets, Net $323,000,000 +17%
Property, Plant and Equipment, Net $144,000,000 +44%
Operating Lease, Right-of-Use Asset $26,000,000 -33%
Goodwill $2,000,000 0%
Other Assets, Noncurrent $27,000,000 -31%
Assets $1,201,000,000 -8.7%
Accounts Payable, Current $48,000,000 -24%
Employee-related Liabilities, Current $103,000,000 +72%
Liabilities, Current $914,000,000 -1.1%
Operating Lease, Liability, Noncurrent $22,000,000 -31%
Other Liabilities, Noncurrent $21,000,000 +17%
Liabilities $1,300,000,000 -21%
Accumulated Other Comprehensive Income (Loss), Net of Tax $30,000,000 +17%
Retained Earnings (Accumulated Deficit) $243,000,000 +45%
Stockholders' Equity Attributable to Parent $98,000,000 +71%
Liabilities and Equity $1,201,000,000 -8.7%
Common Stock, Shares, Issued 125,000,000 0%
Common Stock, Par or Stated Value Per Share 0.5 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $195,000,000 -39%
Deferred Tax Assets, Valuation Allowance $55,000,000 +17%
Deferred Tax Assets, Gross $381,000,000 +15%
Operating Lease, Liability $32,000,000 -24%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $216,000,000 +21500%
Lessee, Operating Lease, Liability, to be Paid $37,000,000 -26%
Property, Plant and Equipment, Gross $251,000,000 +32%
Operating Lease, Liability, Current $10,000,000 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two $11,000,000 -8.3%
Lessee, Operating Lease, Liability, to be Paid, Year One $12,000,000 -7.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 -12%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5,000,000 -38%
Lessee, Operating Lease, Liability, to be Paid, Year Three $8,000,000 -27%
Deferred Tax Assets, Operating Loss Carryforwards $128,000,000 -16%
Unrecognized Tax Benefits $5,000,000 +25%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,000,000 -86%
Additional Paid in Capital $112,000,000 +24%
Deferred Tax Assets, Net of Valuation Allowance $326,000,000 +15%
Share-based Payment Arrangement, Expense $26,000,000 +8.3%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY